BARTOLETTI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 2.150
AS - Asia 1.009
EU - Europa 587
SA - Sud America 142
AF - Africa 29
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.920
Nazione #
US - Stati Uniti d'America 2.106
SG - Singapore 479
CN - Cina 196
BR - Brasile 112
IT - Italia 101
VN - Vietnam 95
HK - Hong Kong 87
DE - Germania 84
RU - Federazione Russa 78
GB - Regno Unito 49
FR - Francia 47
UA - Ucraina 45
BD - Bangladesh 41
FI - Finlandia 41
IN - India 34
IE - Irlanda 30
SE - Svezia 29
CA - Canada 23
ES - Italia 17
BE - Belgio 16
PL - Polonia 14
TR - Turchia 13
EG - Egitto 12
MX - Messico 12
JP - Giappone 10
NL - Olanda 10
AR - Argentina 8
ID - Indonesia 8
KR - Corea 8
VE - Venezuela 8
EC - Ecuador 7
ZA - Sudafrica 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
LT - Lituania 4
PK - Pakistan 4
CO - Colombia 3
RO - Romania 3
BO - Bolivia 2
CL - Cile 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 3.920
Città #
Singapore 248
Ashburn 239
Chandler 193
San Jose 153
Fairfield 132
Woodbridge 110
Beijing 93
Ann Arbor 91
Hong Kong 85
Council Bluffs 74
Houston 67
Seattle 63
New York 52
Wilmington 51
Boardman 45
Cambridge 44
Los Angeles 41
Lauterbourg 33
Ho Chi Minh City 30
Munich 30
Dublin 27
Princeton 27
Dearborn 23
Helsinki 23
Dong Ket 19
Jacksonville 18
Dallas 17
Frankfurt am Main 16
Hanoi 16
Redmond 16
Brussels 15
Buffalo 15
São Paulo 15
Santa Clara 14
Warsaw 13
London 12
Montreal 12
Redondo Beach 12
Nuremberg 11
Turku 11
Chicago 10
Poplar 10
The Dalles 10
Chennai 9
Izmir 9
Martignacco 9
Ogden 9
Orem 9
San Diego 9
Stockholm 9
Tokyo 9
Denver 8
Hefei 8
Des Moines 7
Belo Horizonte 6
Boston 6
Brooklyn 6
City of London 6
Hyderabad 6
Newark 6
Seoul 6
Washington 6
Augusta 5
Düsseldorf 5
Haiphong 5
Johannesburg 5
Milan 5
Phoenix 5
San Francisco 5
Shanghai 5
Toronto 5
Andover 4
Baku 4
Brno 4
Falls Church 4
Hải Dương 4
Leawood 4
Manchester 4
Miami 4
Philadelphia 4
San Mateo 4
Udine 4
Zoppola 4
Al Qahirah al Jadidah 3
Athens 3
Baghdad 3
Belluno 3
Bắc Ninh 3
Caracas 3
Charlotte 3
Genoa 3
Jinan 3
Madrid 3
Majano 3
Medina 3
Mexico City 3
Nanjing 3
New Delhi 3
Portsmouth 3
Querétaro 3
Totale 2.523
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 217
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 199
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 193
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 192
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 181
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 156
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 152
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 146
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 140
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 133
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 132
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 125
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 124
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 118
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 113
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 111
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 104
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 102
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group 89
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 88
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 88
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 87
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 86
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study 84
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 83
Managing COVID-19 in the oncology clinic and avoiding the distraction effect 82
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 76
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer 76
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer 75
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization 74
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 70
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 56
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer 53
Evaluating the role of secondary surgery and PARP inhibition in platinum-sensitive ovarian cancer relapse 41
Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer 26
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer 20
Totale 4.038
Categoria #
all - tutte 16.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022256 20 17 6 7 9 7 16 8 1 38 95 32
2022/2023381 32 42 9 50 42 83 1 37 61 3 11 10
2023/2024187 19 16 15 9 31 44 0 10 12 9 0 22
2024/2025723 31 41 28 42 46 31 66 46 76 69 93 154
2025/20261.652 201 123 91 143 261 143 182 69 153 122 153 11
Totale 4.038